Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Analysis of two autoimmunity genes, IRAK1 and MECP2, in giant cell arteritis.

Márquez A, Solans R, Hernández-Rodríguez J, Cid MC, Castañeda S, Ramentol M, Morado IC, Rodriguez-Rodriguez L, Narváez J, Gómez-Vaquero C, Miranda-Filloy JA, Martínez-Taboada VM, Ríos R, Sopeña B, Monfort J, García-Villanueva MJ, Martínez-Zapico A, Marí-Alfonso B, Sánchez-Martín J, Unzurrunzaga A, Raya E, de Miguel E, Hidalgo-Conde A, Blanco R, González-Gay MÁ, Martín J; Spanish GCA Consortium..

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S30-3.

PMID:
24709033
2.

New insight on the Xq28 association with systemic sclerosis.

Carmona FD, Cénit MC, Diaz-Gallo LM, Broen JC, Simeón CP, Carreira PE, Callejas-Rubio JL, Fonollosa V, López-Longo FJ, González-Gay MA, Hunzelmann N, Riemekasten G, Witte T, Kreuter A, Distler JH, Madhok R, Shiels P, van Laar JM, Schuerwegh AJ, Vonk MC, Voskuyl AE, Fonseca C, Denton CP, Herrick A, Worthington J, Arnett FC, Tan FK, Assassi S, Radstake TR, Mayes MD, Martín J; Spanish Scleroderma Group..

Ann Rheum Dis. 2013 Dec;72(12):2032-8. doi: 10.1136/annrheumdis-2012-202742.

3.

Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Kaufman KM, Zhao J, Kelly JA, Hughes T, Adler A, Sanchez E, Ojwang JO, Langefeld CD, Ziegler JT, Williams AH, Comeau ME, Marion MC, Glenn SB, Cantor RM, Grossman JM, Hahn BH, Song YW, Yu CY, James JA, Guthridge JM, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Ramsey-Goldman R, Petri MA, Reveille JD, Vilá LM, Anaya JM, Boackle SA, Stevens AM, Freedman BI, Criswell LA, Pons Estel BA; Argentine Collaborative Group., Lee JH, Lee JS, Chang DM, Scofield RH, Gilkeson GS, Merrill JT, Niewold TB, Vyse TJ, Bae SC, Alarcón-Riquelme ME; BIOLUPUS network., Jacob CO, Moser Sivils K, Gaffney PM, Harley JB, Sawalha AH, Tsao BP.

Ann Rheum Dis. 2013 Mar;72(3):437-44. doi: 10.1136/annrheumdis-2012-201851.

4.

Autoimmune disease-associated CD226 gene variants are not involved in giant cell arteritis susceptibility in the Spanish population.

Serrano A, Carmona FD, Miranda-Filloy JA, Castañeda S, Rodríguez-Rodríguez L, Morado IC, Gómez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S29-33.

PMID:
22512842
5.

Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis.

Han TU, Cho SK, Kim T, Joo YB, Bae SC, Kang C.

Arthritis Rheum. 2013 Mar;65(3):590-8. doi: 10.1002/art.37804.

6.

Association of CD24 gene polymorphisms with susceptibility to biopsy-proven giant cell arteritis.

Rueda B, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2008 May;35(5):850-4.

PMID:
18381780
7.

Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Gamallo C, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernadez-Gutierrez B, Castañeda S, Morado IC, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):40-5.

PMID:
20412701
8.

C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain.

Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2009 Feb;36(2):341-6. doi: 10.3899/jrheum.080707.

PMID:
19040303
9.

MCP-1 gene haplotype association in biopsy proven giant cell arteritis.

Amoli MM, Salway F, Zeggini E, Ollier WE, Gonzalez-Gay MA.

J Rheumatol. 2005 Mar;32(3):507-10.

PMID:
15742444
10.

Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain.

Rueda B, Roibas B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2007 Jul;34(7):1535-9.

PMID:
17552041
11.

Variants in IRAK1-MECP2 region confer susceptibility to autoimmune thyroid diseases.

Song RH, Qin Q, Yan N, Muhali FS, Meng S, He ST, Zhang JA.

Mol Cell Endocrinol. 2015 Jan 5;399:244-9. doi: 10.1016/j.mce.2014.10.013.

PMID:
25458699
12.

Role of the rs6822844 gene polymorphism at the IL2-IL21 region in biopsy-proven giant cell arteritis.

Rodríguez-Rodríguez L, Castañeda S, Vázquez-Rodríguez TR, Morado IC, Gómez-Vaquero C, Marí-Alfonso B, Miranda-Filloy JA, Narvaez J, Ortego-Centeno N, Vicente EF, Blanco R, Amigo-Diaz E, Fernández-Gutiérrez B, Martin J, González-Gay MA.

Clin Exp Rheumatol. 2011 Jan-Feb;29(1 Suppl 64):S12-6.

PMID:
21269573
13.

Lack of association between IFNGR1 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez T, Castañeda S, Morado IC, Miranda-Filloy JA, Amigo-Diaz E, Callejas-Rubio JL, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2010 Jan-Feb;28(1 Suppl 57):31-4.

PMID:
20412699
14.

Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis.

Gonzalez-Gay MA, Oliver J, Orozco G, Garcia-Porrua C, Lopez-Nevot MA, Martin J.

J Rheumatol. 2005 Aug;32(8):1510-2.

PMID:
16078327
15.

A nonsynonymous functional variant of the ITGAM gene is not involved in biopsy-proven giant cell arteritis.

Carmona FD, Serrano A, Rodríguez-Rodríguez L, Castañeda S, Miranda-Filloy JA, Morado IC, Narváez J, Solans R, Sopeña B, Marí-Alfonso B, Unzurrunzaga A, Ortego-Centeno N, Blanco R, de Miguel E, Hidalgo-Conde A, Martín J, González-Gay MA.

J Rheumatol. 2011 Dec;38(12):2598-601. doi: 10.3899/jrheum.110685.

PMID:
21965647
16.

Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis.

Palomino-Morales RJ, Vazquez-Rodriguez TR, Torres O, Morado IC, Castañeda S, Miranda-Filloy JA, Callejas-Rubio JL, Fernandez-Gutierrez B, Gonzalez-Gay MA, Martin J.

Arthritis Res Ther. 2010;12(2):R51. doi: 10.1186/ar2962.

17.

Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis.

Serrano A, Márquez A, Mackie SL, Carmona FD, Solans R, Miranda-Filloy JA, Hernández-Rodríguez J, Cid MC, Castañeda S, Morado IC, Narváez J, Blanco R, Sopeña B, García-Villanueva MJ, Monfort J, Ortego-Centeno N, Unzurrunzaga A, Marí-Alfonso B, Sánchez-Martín J, de Miguel E, Magro C, Raya E, Braun N, Latus J, Molberg O, Lie BA, Moosig F, Witte T, Morgan AW, González-Gay MA, Martín J; UK GCA Consortium Spanish GCA Consortium..

Ann Rheum Dis. 2013 Nov;72(11):1882-6. doi: 10.1136/annrheumdis-2013-203641.

18.

Influence of the IL17A locus in giant cell arteritis susceptibility.

Márquez A, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Fernández-Contreras ME, Ramentol M, Morado IC, Narváez J, Gómez-Vaquero C, Martínez-Taboada VM, Ortego-Centeno N, Sopeña B, Monfort J, García-Villanueva MJ, Caminal-Montero L, de Miguel E, Blanco R; Spanish GCA Consortium., Palm O, Molberg O, Latus J, Braun N, Moosig F, Witte T, Beretta L, Santaniello A, Pazzola G, Boiardi L, Salvarani C, González-Gay MA, Martín J.

Ann Rheum Dis. 2014 Sep;73(9):1742-5. doi: 10.1136/annrheumdis-2014-205261.

PMID:
24919468
19.

A case-control study suggests that the CCR6 locus is not involved in the susceptibility to giant cell arteritis.

Serrano A, Carmona FD, Castañeda S, Miranda-Filloy JA, Morado IC, Gomez-Vaquero C, Solans R, Sopeña B, Blanco R, Unzurrunzaga A, Ortego-Centeno N, Marí-Alfonso B, Hidalgo-Conde A, Hernández-Rodríguez J, Cid MC, Martín J, Gonzalez-Gay MA.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S5-8.

PMID:
23306142
20.

Lack of association between TRAF1/C5 gene polymorphisms and biopsy-proven giant cell arteritis.

Torres O, Palomino-Morales R, Vazquez-Rodriguez TR, Castañeda S, Morado IC, Miranda-Filloy JA, Ortego-Centeno N, Gonzalez-Alvaro I, Fernandez-Gutierrez B, Martin J, Gonzalez-Gay MA.

J Rheumatol. 2010 Jan;37(1):131-5. doi: 10.3899/jrheum.090646.

PMID:
19918040
Items per page

Supplemental Content

Support Center